News

Industry news, press releases, and official statements from USIJ.
  • All News
  • Alliance News
  • Amicus Briefs
  • Comments & Letters
  • Industry News
  • Op-Eds
  • Statements & Releases
  • White Papers
All News
  • All News
  • Alliance News
  • Amicus Briefs
  • Comments & Letters
  • Industry News
  • Op-Eds
  • Statements & Releases
  • White Papers
attachment 607dc579a2046575e250a127
Opinion: Waiving vaccine patents would imperil public health
attachment 607dc48a0a86fe67d94444d5
No evidence that patents slow access to vaccines
USIJ Comments to NIST Proposed Rule, “Rights Federally Funded Inventions and Licensing of Government Owned Inventions.”
USIJ Applauds FTC for Declining to Appeal its Case Against Qualcomm to the Supreme Court
USIJ Urges President Biden to Select USPTO Director who is Committed to Upholding a Strong Patent System
attachment 602543ce33062106006e9f5a
USIJ to Supremes: Set Boundaries on 101 Jurisprudence to Save U.S. Innovation
USIJ Comments on Discretion to Institute Trials Before the Patent Trial and Appeal Board
attachment 5f7dbf4714c095073cd0003b
Google And Oracle’s Decade-Long Copyright Battle Reaches Supreme Court
USIJ Letter to Congress Supporting Director Iancu’s Efforts to Improve PTAB
attachment 5f4da512ad09bd44e5ae8a25
If we want innovation, companies must be able to rely on patent law to protect their investments

Sign up to receive news and updates from USIJ.

"*" indicates required fields

Name*
By signing up for the newsletter, you agree to the terms of use.
This field is for validation purposes and should be left unchanged.
Scroll to Top